Cite
HARVARD Citation
Rezaee, M. et al. (2020). Are We Overstating the Risk of Priapism with Oral Phosphodiesterase Type 5 Inhibitors?. Journal of sexual medicine. 17 (8), pp. 1579-1582. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rezaee, M. et al. (2020). Are We Overstating the Risk of Priapism with Oral Phosphodiesterase Type 5 Inhibitors?. Journal of sexual medicine. 17 (8), pp. 1579-1582. [Online].